Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. S-3 Offering Registration Statement
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. 8-K Event Material agreement · Results of operations · Unregistered share sale · Other events
  20. 424B5 Offering Prospectus

Page 6 of 19 · 362 filings